tirzepatide fda shortage list Lilly's weight-loss drug removed from FDA's Lilly's Tirzepatide Could Land Again

*Compounded Tirzepatide available through Rixa Health's GLP-1 Prescription is produced in an FDA-registered facility but has not been evaluated by the FDA for safety, efficacy, or quality

Having multiple options reduces anxiety about access

Semaglutides (the active ingredient in Wegovy and Ozempic) role in promoting weight loss is rooted in its ability to mimic the natural actions of the glucagon-like peptide-1 (GLP-1) hormone

Approved Food Your browser does not support JavaScript!

Ethics declarations Conflict of Interest Swarna Khare, Beatrice Osumili, and Nele Debackere are employees and shareholders of Eli Lilly and Company